Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Income from Continuing Operations (2023 - 2025)

Rallybio (RLYB) has disclosed Income from Continuing Operations for 3 consecutive years, with 5852000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations rose 44.87% to 5852000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 8104000.0 through Dec 2025, up 85.41% year-over-year, with the annual reading at 8104000.0 for FY2025, 85.41% up from the prior year.
  • Income from Continuing Operations hit 5852000.0 in Q4 2025 for Rallybio, down from 16016000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 16016000.0 in Q3 2025 to a low of 19629000.0 in Q4 2023.
  • Historically, Income from Continuing Operations has averaged 11346916.67 across 3 years, with a median of 13289000.0 in 2024.
  • Biggest five-year swings in Income from Continuing Operations: fell 9.48% in 2024 and later surged 247.9% in 2025.
  • Year by year, Income from Continuing Operations stood at 19629000.0 in 2023, then soared by 45.93% to 10614000.0 in 2024, then soared by 44.87% to 5852000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for RLYB at 5852000.0 in Q4 2025, 16016000.0 in Q3 2025, and 9416000.0 in Q2 2025.